"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Mental health treatment has evolved significantly over the years, offering new hope for individuals dealing with conditions .

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

In the absence of clinical improvement or if symptoms worsen after initial treatment, administer a second dose of neffy in the same nostril with a new nasal spray starting 5 minutes after the ...

The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

According to doctors people with compromised immunity and allergic issues are prone to acute respiratory problems ...